About this trial
Glomerulonephritis (GN) generates an enormous individual and social economic burden. However, the therapeutic options are largely based on clinical and pathological parameters and the individual response to therapy or prognosis is uncertain.
Recently, along with advances in molecular analysis and computational bioinformatics, genomic data from human renal biopsies could provide a strong foundation for the future of precision medicine in nephrology.
In response to a request for applications by the Ministry of Health and Welfare of Korea for the creation of Clinical Research Registry, multi-center N network has been established for prospective cohort with kidney biopsy samples (KORNERSTONE).
Through this Network the investigators hope to understand the fundamental biology of glomerulonephritis and aim to bank long-term observational data and corresponding biological data including genomic data from kidney tissues, and kidney pathologic data which is digitalized This database is archived to a web-based platform to access easily and further enrich for researchers.
Eligibility criteria
Qualifiers
* Patient suspected of glomerular disease who received kidney biopsy in participating university medical centers
Children (age<18 years) also included
Disqualifiers
Patients who previously received a kidney transplant
Trial design
Treatments tested in this trial
- Kidney Biopsy
Treatment groups
Sponsors and collaborators
Seoul National University Hospital
Lead sponsor
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Collaborator
KangWon National University Hospital
Collaborator
Keimyung University Dongsan Medical Center
Collaborator
SMG-SNU Boramae Medical Center
Collaborator
Seoul National University Bundang Hospital
Collaborator
Severance Hospital
Collaborator
Ministry of Health & Welfare, Korea
Collaborator